These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38862069)
21. An Outbreak of ST859-K19 Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae in a Chinese Teaching Hospital. Zhu J; Jiang X; Zhao L; Li M mSystems; 2022 Jun; 7(3):e0129721. PubMed ID: 35574716 [TBL] [Abstract][Full Text] [Related]
22. [Analysis of molecular and clinical characteristics of carbapenem-resistant hypervirulent Lei J; Zhou WX; Lei K; Chen D; Zhang PQ; Xue L; Geng Y Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jan; 56(1):63-68. PubMed ID: 35092993 [TBL] [Abstract][Full Text] [Related]
23. Alcohol-associated intestinal dysbiosis impairs pulmonary host defense against Klebsiella pneumoniae. Samuelson DR; Shellito JE; Maffei VJ; Tague ED; Campagna SR; Blanchard EE; Luo M; Taylor CM; Ronis MJJ; Molina PE; Welsh DA PLoS Pathog; 2017 Jun; 13(6):e1006426. PubMed ID: 28604843 [TBL] [Abstract][Full Text] [Related]
24. Nosocomial transmission and rearrangement of large resistance-virulence hybrid plasmids between two bacteremic ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae strains with low fitness cost. Liao W; Huang QS; Wei D; Xiong Z; Du FL; Xiang TX; Zhang S; Wan LG; Zhang W; Liu Y Microb Pathog; 2022 Jul; 168():105593. PubMed ID: 35595177 [TBL] [Abstract][Full Text] [Related]
25. The making of hypervirulent Klebsiella pneumoniae. Dai P; Hu D J Clin Lab Anal; 2022 Dec; 36(12):e24743. PubMed ID: 36347819 [TBL] [Abstract][Full Text] [Related]
26. Clinical evolution of ST11 carbapenem resistant and hypervirulent Klebsiella pneumoniae. Xie M; Yang X; Xu Q; Ye L; Chen K; Zheng Z; Dong N; Sun Q; Shu L; Gu D; Chan EW; Zhang R; Chen S Commun Biol; 2021 Jun; 4(1):650. PubMed ID: 34075192 [TBL] [Abstract][Full Text] [Related]
27. Alterations in the Gut Microbiome and Cecal Metabolome During Wu T; Xu F; Su C; Li H; Lv N; Liu Y; Gao Y; Lan Y; Li J Front Immunol; 2020; 11():1331. PubMed ID: 32849494 [No Abstract] [Full Text] [Related]
28. Outer Membrane Vesicles Transmitting Tang B; Yang A; Liu P; Wang Z; Jian Z; Chen X; Yan Q; Liang X; Liu W Antimicrob Agents Chemother; 2023 May; 67(5):e0144422. PubMed ID: 37052502 [TBL] [Abstract][Full Text] [Related]
29. Discovery of anti-mucoviscous activity of rifampicin and its potential as a candidate antivirulence agent against hypervirulent Klebsiella pneumoniae. Namikawa H; Oinuma KI; Sakiyama A; Tsubouchi T; Tahara YO; Yamada K; Niki M; Takemoto Y; Miyata M; Kaneko Y; Shuto T; Kakeya H Int J Antimicrob Agents; 2019 Aug; 54(2):167-175. PubMed ID: 31173862 [TBL] [Abstract][Full Text] [Related]
31. "Superbugs" with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China. Pu D; Zhao J; Chang K; Zhuo X; Cao B Sci Bull (Beijing); 2023 Nov; 68(21):2658-2670. PubMed ID: 37821268 [TBL] [Abstract][Full Text] [Related]
32. Hypervirulent Klebsiella pneumoniae Infections in Pediatric Populations in Beijing (2017-2019): Clinical Characteristics, Molecular Epidemiology and Antimicrobial Susceptibility. Li Y; Dong L; Gao W; Zhen J; Dong F; Yao K Pediatr Infect Dis J; 2021 Dec; 40(12):1059-1063. PubMed ID: 34269324 [TBL] [Abstract][Full Text] [Related]
33. Clinical and microbiological characteristics of hypervirulent Klebsiella pneumoniae (hvKp) in a hospital from North China. Yang Y; Liu JH; Hu XX; Zhang W; Nie TY; Yang XY; Wang XK; Li CR; You XF J Infect Dev Ctries; 2020 Jun; 14(6):606-613. PubMed ID: 32683351 [TBL] [Abstract][Full Text] [Related]
34. Transient neonatal antibiotic exposure increases susceptibility to late-onset sepsis driven by microbiota-dependent suppression of type 3 innate lymphoid cells. Niu X; Daniel S; Kumar D; Ding EY; Savani RC; Koh AY; Mirpuri J Sci Rep; 2020 Jul; 10(1):12974. PubMed ID: 32737397 [TBL] [Abstract][Full Text] [Related]
35. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Schuijt TJ; Lankelma JM; Scicluna BP; de Sousa e Melo F; Roelofs JJ; de Boer JD; Hoogendijk AJ; de Beer R; de Vos A; Belzer C; de Vos WM; van der Poll T; Wiersinga WJ Gut; 2016 Apr; 65(4):575-83. PubMed ID: 26511795 [TBL] [Abstract][Full Text] [Related]
36. Antimicrobial Resistance and Pathogenicity Determination of Community-Acquired Hypervirulent Gao Q; Shen Z; Qin J; Liu Y; Li M Microb Drug Resist; 2020 Oct; 26(10):1195-1200. PubMed ID: 32354302 [TBL] [Abstract][Full Text] [Related]
37. Host immunity involvement in the outcome of phage therapy against hypervirulent Tang M; Yao Z; Liu Y; Ma Z; Zhao D; Mao Z; Wang Y; Chen L; Zhou T Antimicrob Agents Chemother; 2024 May; ():e0142923. PubMed ID: 38742895 [TBL] [Abstract][Full Text] [Related]
39. [Investigation of Virulence Genes and Carbapenem Resistance Genes in Hypervirulent and Classical Isolates of Klebsiella pneumoniae Isolated from Various Clinical Specimens]. Yürek M; Cevahir N Mikrobiyol Bul; 2023 Apr; 57(2):188-206. PubMed ID: 37067205 [TBL] [Abstract][Full Text] [Related]
40. Persistent transmission of carbapenem-resistant, hypervirulent Klebsiella pneumoniae between a hospital and urban aquatic environments. Zou H; Zhou Z; Berglund B; Zheng B; Meng M; Zhao L; Zhang H; Wang Z; Wu T; Li Q; Li X Water Res; 2023 Aug; 242():120263. PubMed ID: 37390655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]